Skip to content

Leocor Corflo Model 7.5PT PTCA Catheter

by Leocor, Inc.

PMA P890001

Active United States

PMA

Valid until

No expiry

PMA approval is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

PMA P890001↗

FDA record

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA PMA, synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA PMAAPPR Approved NumberP890001 Date30 Mar 1990ApprovedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 22 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA PMA Active

Specification

PMA

Full name
Leocor Corflo(Tm) Model 7.5PT Ptca Catheter
Trade Name
Leocor,inc. Models 1
Generic Name
Catheters, transluminal coronary angioplasty, percutaneous
PMA Number
FDA Product Code
LOX
Device Class
Class II
Regulation
21 CFR Part 870.5100
Advisory Committee
Cardiovascular
FDA Decision
APPR Approved

Overview

AI-generated summary, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Leocor Corflo Model 7.5PT PTCA Catheter is a Catheter, Transluminal Coronary Angioplasty, Percutaneous, designed for use in percutaneous transluminal coronary angioplasty (PTCA) procedures. It is intended to dilate narrowed or obstructed coronary arteries by inflating a balloon at the catheter tip, restoring blood flow to the affected region.

This catheter is supplied as a single-use device and is regulated under the FDA_PMA authorization, with approval granted under PMA number P890001. It is classified as a Class II medical device under regulation number 870.5100 and is intended for use in controlled clinical settings, such as cardiac catheterization labs. The device is not labeled for MRI use and must be stored in accordance with manufacturer instructions to maintain sterility and functionality.

Other devices from Leocor, Inc.

Questions

AI-generated answers, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the primary clinical purpose of the Leocor Corflo Model 7.5PT PTCA Catheter, and where would it typically be used?

    The Leocor Corflo Model 7.5PT PTCA Catheter is specifically designed for percutaneous transluminal coronary angioplasty (PTCA), a procedure to widen narrowed or blocked coronary arteries. It achieves this by inflating a balloon at the catheter tip, restoring blood flow to the affected area. This device is intended for use in controlled clinical settings, such as cardiac catheterization labs, where interventional cardiologists perform coronary artery interventions.

  • Is the Leocor Corflo Model 7.5PT PTCA Catheter intended for reuse, or is it single-use only?

    The device is explicitly labeled as single-use only, meaning it is not designed for reuse after a single procedure. This ensures patient safety and sterility, as reuse could compromise the device’s integrity and introduce infection risks.

  • How should the Leocor Corflo Model 7.5PT PTCA Catheter be stored to maintain its sterility and functionality?

    The manufacturer instructs that the device must be stored in accordance with their specific guidelines to preserve sterility and functionality. While the exact storage conditions (e.g., temperature, packaging) aren’t detailed here, standard practice for single-use catheters typically involves keeping them in their original, sealed packaging in a clean, dry environment away from direct sunlight or extreme temperatures until use.

  • What regulatory pathway was followed for the approval of this device, and what classification does it hold?

    The Leocor Corflo Model 7.5PT PTCA Catheter was approved through the FDA’s Premarket Approval (PMA) process, with approval granted under PMA number P890001. It is classified as a Class II medical device under regulation number 870.5100, indicating it requires a higher level of scrutiny due to its role in life-sustaining or life-supporting procedures.